Laurel Burst, - Speech-Language Pathologist in Anchorage, AK

Laurel Burst, is a Speech-language Pathologist based in Anchorage, Alaska. Laurel Burst is licensed to practice in Alaska (license number 205222) and her current practice location is 235 E 9th Ave, Anchorage, Alaska. She can be reached at her office (for appointments etc.) via phone at (907) 334-9001.

NPI number for Laurel Burst is 1447957477 and her current mailing address is 1221 Shore Dr, Anchorage, Alaska. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1447957477.

Contact Information

Laurel Burst,
235 E 9th Ave,
Anchorage, AK 99501-7501
(907) 334-9001
Not Available



Healthcare Provider's Profile

Full NameLaurel Burst
GenderFemale
SpecialitySpeech-language Pathologist
Location235 E 9th Ave, Anchorage, Alaska
Accepts Medicare AssignmentsDoes not participate in Medicare Program. She may not accept medicare assignment.
  NPI Data:
  • NPI Number: 1447957477
  • Provider Enumeration Date: 02/09/2023
  • Last Update Date: 02/09/2023

Medical Identifiers

Medical identifiers for Laurel Burst such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1447957477NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
235Z00000XSpeech-language Pathologist 205222 (Alaska)Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Laurel Burst is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Laurel Burst,
1221 Shore Dr,
Anchorage, AK 99515-3204

Ph: (843) 291-3257
Laurel Burst,
235 E 9th Ave,
Anchorage, AK 99501-7501

Ph: (907) 334-9001

News Archive

Phase III trials for CS-8958 neuraminidase inhibitor successful

Hovione is pleased to announce that its TwinCaps(R) inhaler licensees Daiichi Sankyo Co. Ltd. (Tokyo, Japan) and Biota Holdings Ltd (Victoria, Australia) have both announced successful Phase III trials for CS-8958, a new long-acting neuraminidase inhibitor for treatment of influenza (known as a prodrug of laninamivir).

Study identifies several risk factors linked to low patient-accrual rates in cancer clinical trials

A new study by researchers at the Hutchinson Institute for Cancer Outcomes Research at Fred Hutchinson Cancer Research Center and the University of Washington has found that 20 percent of cancer clinical trials fail to draw enough participants to render verdicts on experimental therapies.

Leading scientists select first drugs to be evaluated in Alzheimer's clinical study

Leading scientists have selected the first drugs to be evaluated in a worldwide clinical study to determine whether they can prevent Alzheimer's disease.

No deal on Medicaid expansion in Va. as lawmakers adjourn

In Virginia, lawmakers also failed to pass a budget or make a deal on proposed mental health legislation. Virginia Gov. Terry McAuliffe promised a special session to settle the budget issue.

Macrolide, penicillin antibiotics in pregnancy could affect children's health

A new study published in the journal BMJ in February 2020 reports that macrolide or penicillin antibiotic consumption in pregnancy could be linked to several adverse health outcomes in children. These include major malformations, cerebral palsy, attention deficit hyperactivity disorder, and autism spectrum disorder.

Read more News

› Verified 5 days ago


Speech-Language Pathologist in Anchorage, AK

Kathryn Cross, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 12350 Industry Way, 202, Anchorage, AK 99515
Phone: 907-301-4588    
Tracey Keaton, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 6927 Old Seward Hwy Ste 100, Anchorage, AK 99518
Phone: 907-345-0050    
Christal Hays, MS CCC SLP
Speech-Language Pathologist
Medicare: Medicare Enrolled
Practice Location: 4441 Diplomacy Dr, Anchorage, AK 99508
Phone: 907-729-8800    
Mrs. Lisa J.c. Rayes, CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4048 Laurel St Ste 303, Anchorage, AK 99508
Phone: 907-562-4550    
Lian Liew Tan, SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4155 Tudor Centre Dr, Suite #103, Anchorage, AK 99508
Phone: 907-854-8624    
Mrs. Yvonne Marie San Juan, M.S., CCC-SLP
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 4241 B St Ste 301, Anchorage, AK 99503
Phone: 907-727-0935    Fax: 907-276-7529
Speak From The Heart Llc
Speech-Language Pathologist
Medicare: Not Enrolled in Medicare
Practice Location: 3351 W 84th Ave, Anchorage, AK 99502
Phone: 907-390-0492    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.